The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-12-13
DOI
10.1002/jcp.30655
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chaetocochin J, an epipolythiodioxopiperazine alkaloid, induces apoptosis and autophagy in colorectal cancer via AMPK and PI3K/AKT/mTOR pathways
- (2021) Song Hu et al. BIOORGANIC CHEMISTRY
- Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis
- (2021) Yali Hu et al. International Journal of Nanomedicine
- Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling
- (2020) Kuilong Wang et al. PHYTOMEDICINE
- Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan‐cancer analysis
- (2020) Haijing Liu et al. Cancer Communications
- Anticancer Effects of Fufang Yiliu Yin Formula on Colorectal Cancer Through Modulation of the PI3K/Akt Pathway and BCL-2 Family Proteins
- (2020) Bingzi Dong et al. Frontiers in Cell and Developmental Biology
- Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
- (2020) Gokhan Ucar et al. MEDICINE
- LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling
- (2019) Jialei Hu et al. INTERNATIONAL JOURNAL OF CANCER
- LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer
- (2019) Shurui Ouyang et al. Cancer Cell International
- Knockdown of long non-coding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p
- (2019) An-Quan Shang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Grape seed procyanidin B2 promotes the autophagy and apoptosis in colorectal cancer cells via regulating PI3K/Akt signaling pathway
- (2019) Ruijuan Zhang et al. OncoTargets and Therapy
- Molecular characterization of colorectal cancer using whole‐exome sequencing in a Taiwanese population
- (2019) Ya‐Sian Chang et al. Cancer Medicine
- PI3K/ Akt/ mTOR pathway as a therapeutic target for colorectal cancer: A review of preclinical and clinical evidence
- (2019) Arunaksharan Narayanankutty CURRENT DRUG TARGETS
- PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
- (2019) Ali S. Alzahrani SEMINARS IN CANCER BIOLOGY
- A phase Ib study of a PI3Kinase inhibitor BKM120 in combination with panitumumab in patients with KRAS wild-type advanced colorectal cancer
- (2019) Rachel Goodwin et al. INVESTIGATIONAL NEW DRUGS
- Long-Non Coding RNA SNHG16 Supports Colon Cancer Cell Growth by Modulating miR-302a-3p/AKT Axis
- (2019) Dong Ke et al. PATHOLOGY & ONCOLOGY RESEARCH
- lncRNA GAS5 Inhibits Cell Migration and Invasion and Promotes Autophagy by Targeting miR-222-3p via the GAS5/PTEN-Signaling Pathway in CRC
- (2019) Lin Liu et al. Molecular Therapy-Nucleic Acids
- BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights
- (2019) Caputo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long Non-Coding RNA TTN-AS1 Promotes the Proliferation and Invasion of Colorectal Cancer Cells by Activating miR-497-Mediated PI3K/Akt/mTOR Signaling
- (2019) Zhenhua Cui et al. OncoTargets and Therapy
- Signaling pathways involved in colorectal cancer progression
- (2019) Zahra Koveitypour et al. Cell and Bioscience
- Long non-coding RNA-422 acts as a tumor suppressor in colorectal cancer
- (2018) Qianwen Shao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Long Noncoding RNA PlncRNA-1 Promotes Colorectal Cancer Cell Progression by Regulating the PI3K/Akt Signaling Pathway
- (2018) Wei Song et al. ONCOLOGY RESEARCH
- PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
- (2018) Qiang Wang et al. Cell Death & Disease
- Suppression of Notch1 and AKT mediated epithelial to mesenchymal transition by Verrucarin J in metastatic colon cancer
- (2018) Deeksha Pal et al. Cell Death & Disease
- Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first–line treatment of metastatic colorectal cancer
- (2018) G. Weldon Gilcrease et al. INVESTIGATIONAL NEW DRUGS
- Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
- (2017) Inés Mármol et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology
- (2017) Antonia R. Sepulveda et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF -Mutant Colorectal Cancer
- (2017) Robin M.J.M. van Geel et al. Cancer Discovery
- The Impact of Cetuximab Plus AKT- or mTOR- Inhibitor in a Patient-Derived Colon Cancer Cell Model with Wild-Type RAS and PIK3CA Mutation
- (2017) Ju Sun Kim et al. Journal of Cancer
- Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer
- (2016) H. Imaoka et al. ANNALS OF ONCOLOGY
- Prognostic role of tumorPIK3CAmutation in colorectal cancer: a systematic review and meta-analysis
- (2016) Z. B. Mei et al. ANNALS OF ONCOLOGY
- Allelic loss at PTEN locus leads to progression of colorectal carcinoma among North Indian patients
- (2016) Asgar Ali et al. BIOMARKERS
- AKT in cancer: new molecular insights and advances in drug development
- (2016) Prabhjot S. Mundi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes
- (2016) Stacey A. Cohen et al. GASTROENTEROLOGY
- Plasma and saliva miR-21 expression in colorectal cancer patients
- (2016) A. A. Sazanov et al. JOURNAL OF APPLIED GENETICS
- Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing
- (2016) Mayank Jauhri et al. MEDICAL ONCOLOGY
- Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway
- (2016) Xiang-Jun Fan et al. ONCOLOGY REPORTS
- Colon microbiota fermentation of dietary prebiotics towards short-chain fatty acids and their roles as anti-inflammatory and antitumour agents: A review
- (2016) Javier Fernández et al. Journal of Functional Foods
- Celastrus orbiculatus extract triggers apoptosis and autophagy via PI3K/Akt/mTOR inhibition in human colorectal cancer cells
- (2016) Lin Yang et al. Oncology Letters
- Downregulation of mir-23b in plasma is associated with poor prognosis in patients with colorectal cancer
- (2016) Chang-Hua Kou et al. Oncology Letters
- Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells
- (2016) Suman Suman et al. Oncotarget
- Specific inhibition of p110α subunit of PI3K: putative therapeutic strategy for KRAS mutant colorectal cancers
- (2016) Maria Sofia Fernandes et al. Oncotarget
- Mechanisms of resistance to anti-EGFR therapy in colorectal cancer
- (2016) Ben Zhao et al. Oncotarget
- Examining plasma microRNA markers for colorectal cancer at different stages
- (2016) Yan Sun et al. Oncotarget
- Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation
- (2015) Nishi Kothari et al. ACTA ONCOLOGICA
- Functional promoter rs2295080 T>G variant in MTOR gene is associated with risk of colorectal cancer in a Chinese population
- (2015) Ming Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- A phase I trial of mFOLFOX6 combined with the oral PI3K inhibitor BKM120 in patients with advanced refractory solid tumors
- (2015) Autumn J. McRee et al. INVESTIGATIONAL NEW DRUGS
- Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer
- (2015) Khanh Do et al. INVESTIGATIONAL NEW DRUGS
- Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway
- (2015) YAN SUN et al. ONCOLOGY REPORTS
- Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis
- (2015) Le-chi Ye et al. TUMOR BIOLOGY
- Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells
- (2015) Cheng-Chia Tsai WORLD JOURNAL OF GASTROENTEROLOGY
- A comprehensive analysis of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss in colorectal cancer
- (2015) Pei-Ching Lin et al. World Journal of Surgical Oncology
- miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR
- (2015) Wenhua Li et al. Oncotarget
- Pterostilbine, an active component of blueberries, sensitizes colon cancer cells to 5-fluorouracil cytotoxicity
- (2015) Mai F. Tolba et al. Scientific Reports
- Targeting the PI3K signaling pathway inKRASmutant colon cancer
- (2015) Suntaek Hong et al. Cancer Medicine
- PIK3CA Mutation in Colorectal Cancer: Relationship with Genetic and Epigenetic Alterations
- (2015) Katsuhiko Nosho et al. NEOPLASIA
- Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer
- (2014) Ekta Agarwal et al. BMC CANCER
- BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients
- (2014) Jing Chen et al. BMC CANCER
- MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1
- (2014) Xin-Ping Huang et al. FEBS Journal
- Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors
- (2014) Jordi Rodon et al. INVESTIGATIONAL NEW DRUGS
- Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway
- (2014) Lijun Xu et al. Journal of Translational Medicine
- PI3K/Akt pathway involving into apoptosis and invasion in human colon cancer cells LoVo
- (2014) Qun Guang Jiang et al. MOLECULAR BIOLOGY REPORTS
- Synthetic Genistein Glycosides Inhibiting EGFR Phosphorylation Enhance the Effect of Radiation in HCT 116 Colon Cancer Cells
- (2014) Aleksandra Gruca et al. MOLECULES
- miR-18a Inhibits CDC42 and Plays a Tumour Suppressor Role in Colorectal Cancer Cells
- (2014) Karen J. Humphreys et al. PLoS One
- AKT1 (E17K) Mutation in Pancreatic Cancer
- (2014) Azim Mohamedali et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- The association of phosphatase and tensin homolog deleted on chromosome 10 polymorphisms and lifestyle habits with colorectal cancer risk in a Chinese population
- (2014) Fangyuan Jing et al. TUMOR BIOLOGY
- The roles of miR-200c in colon cancer and associated molecular mechanisms
- (2014) Jianmei Chen et al. TUMOR BIOLOGY
- Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer
- (2014) Zhong-chuan Lv et al. TUMOR BIOLOGY
- Anti-EGFR and anti-VEGF agents: Important targeted therapies of colorectal liver metastases
- (2014) Qing-Yang Feng WORLD JOURNAL OF GASTROENTEROLOGY
- Evolving treatment strategies for colorectal cancer: A critical review of current therapeutic options
- (2014) Daniel C Damin WORLD JOURNAL OF GASTROENTEROLOGY
- Aberrant Expression of MicroRNA-15a and MicroRNA-16 Synergistically Associates with Tumor Progression and Prognosis in Patients with Colorectal Cancer
- (2014) Guangfa Xiao et al. Gastroenterology Research and Practice
- Phase II trial of temsirolimus alone and in combination with irinotecan forKRASmutant metastatic colorectal cancer: Outcome and results ofKRASmutational analysis in plasma
- (2013) Karen-Lise G. Spindler et al. ACTA ONCOLOGICA
- The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
- (2013) V Eklöf et al. BRITISH JOURNAL OF CANCER
- The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
- (2013) E Mogilyansky et al. CELL DEATH AND DIFFERENTIATION
- PIK3CA and PTEN Gene and Exon Mutation-Specific Clinicopathologic and Molecular Associations in Colorectal Cancer
- (2013) F. L. Day et al. CLINICAL CANCER RESEARCH
- microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2
- (2013) W.-T. Liao et al. CLINICAL CANCER RESEARCH
- MicroRNA-92a Functions as an Oncogene in Colorectal Cancer by Targeting PTEN
- (2013) Guangjun Zhang et al. DIGESTIVE DISEASES AND SCIENCES
- Long Noncoding RNAs: Past, Present, and Future
- (2013) J. T. Y. Kung et al. GENETICS
- Altered PTEN function caused by deletion or gene disruption is associated with poor prognosis in rectal but not in colon cancer
- (2013) B.A. Bohn et al. HUMAN PATHOLOGY
- Promising biomarkers for predicting the outcomes of patients withKRASwild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysis
- (2013) Zu-Yao Yang et al. INTERNATIONAL JOURNAL OF CANCER
- KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy
- (2013) Emanuele Valtorta et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer
- (2013) Prasanth Ganesan et al. INVESTIGATIONAL NEW DRUGS
- PIK3CA mutation is associated with poor survival among patients with metastatic colorectal cancer following anti-EGFR monoclonal antibody therapy: a meta-analysis
- (2013) Shuangjie Wu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
- (2013) Enric Domingo et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic implications of serum microRNA-21 in colorectal cancer
- (2013) Pablo Menéndez et al. JOURNAL OF SURGICAL ONCOLOGY
- Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial
- (2013) Shuji Ogino et al. JNCI-Journal of the National Cancer Institute
- Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263
- (2013) H. Shao et al. MOLECULAR CANCER THERAPEUTICS
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer
- (2013) Q Ye et al. ONCOGENE
- Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer
- (2013) J Wang et al. ONCOGENE
- Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells
- (2013) Margarita González-Vallinas et al. PHARMACOLOGICAL RESEARCH
- Combined 5-FU and ChoKα Inhibitors as a New Alternative Therapy of Colorectal Cancer: Evidence in Human Tumor-Derived Cell Lines and Mouse Xenografts
- (2013) Ana de la Cueva et al. PLoS One
- PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival
- (2013) Christophe Rosty et al. PLoS One
- Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing
- (2013) Sae-Won Han et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway
- (2013) Burhan Hassan et al. Surgical Oncology Clinics of North America
- Comprehensive identification of mutational cancer driver genes across 12 tumor types
- (2013) David Tamborero et al. Scientific Reports
- Combination of TNF-α and graphene oxide-loaded BEZ235 to enhance apoptosis of PIK3CA mutant colorectal cancer cells
- (2013) Yuhua Cao et al. Journal of Materials Chemistry B
- Beyond KRAS mutation status: influence of KRAScopy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
- (2012) Leonie JM Mekenkamp et al. BMC CANCER
- Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines
- (2012) Fatima Rangwala et al. BMC CANCER
- The Role of MicroRNAs in Colorectal Cancer
- (2012) Aaron J. Schetter et al. CANCER JOURNAL
- Characteristics and prevalence of KRAS, BRAF, and PIK3CA mutations in colorectal cancer by high-resolution melting analysis in Taiwanese population
- (2012) Li-Ling Hsieh et al. CLINICA CHIMICA ACTA
- A Multicenter Phase I Trial of PX-866, an Oral Irreversible Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Advanced Solid Tumors
- (2012) D. S. Hong et al. CLINICAL CANCER RESEARCH
- Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
- (2012) X. Liao et al. CLINICAL CANCER RESEARCH
- Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents
- (2012) M. Mao et al. CLINICAL CANCER RESEARCH
- Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
- (2012) M.-H. Tan et al. CLINICAL CANCER RESEARCH
- Association betweenPTENIVS4 polymorphism and development of colorectal cancer in a Turkish population
- (2012) Emel Canbay et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy
- (2012) Thomas C. Wehler et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells
- (2012) BINGHONG XIONG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Use of multivariate analysis to suggest a new molecular classification of colorectal cancer
- (2012) Enric Domingo et al. JOURNAL OF PATHOLOGY
- Recurrent R-spondin fusions in colon cancer
- (2012) Somasekar Seshagiri et al. NATURE
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phosphatase and tensin homolog expression related to cetuximab effects in colorectal cancer patients: A meta-analysis
- (2012) Yue Shen WORLD JOURNAL OF GASTROENTEROLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis
- (2011) C. Mao et al. ANNALS OF ONCOLOGY
- The human epidermal growth factor receptor (EGFR) gene in European patients with advanced colorectal cancer harbors infrequent mutations in its tyrosine kinase domain
- (2011) Brigitte Metzger et al. BMC Medical Genetics
- Genome-wide Profiling of Chromatin Signatures Reveals Epigenetic Regulation of MicroRNA Genes in Colorectal Cancer
- (2011) H. Suzuki et al. CANCER RESEARCH
- Resveratrol Potentiates the Cytotoxic Oxidative Stress Induced by Chemotherapy in Human Colon Cancer Cells
- (2011) Francisca M. Santandreu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer
- (2011) H.-K. Oh et al. CLINICAL CANCER RESEARCH
- Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer
- (2011) Cecily P. Vaughn et al. GENES CHROMOSOMES & CANCER
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- (2011) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Significance of Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway in Korean Patients with Colorectal Cancer
- (2011) Jong Gwang Kim et al. ONCOLOGY
- Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
- (2011) Hanyin Cheng et al. PLoS One
- Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases
- (2011) Oscar Vadas et al. Science Signaling
- PIK3CA mutation and methylation influences the outcome of colorectal cancer
- (2011) SATORU IIDA et al. Oncology Letters
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up
- (2010) R. Labianca et al. ANNALS OF ONCOLOGY
- Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR , PTEN , STK11 , RPKAA1 , PRKAG2 , TSC1 , TSC2 , PI3K and Akt1
- (2010) Martha L. Slattery et al. CARCINOGENESIS
- Activating E17K mutation in the gene encoding the protein kinase AKT in a subset of squamous cell carcinoma of the lung
- (2010) Donatella Malanga et al. CELL CYCLE
- NRAS Mutations Are Rare in Colorectal Cancer
- (2010) Natsumi Irahara et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- The Chromosomal Instability Pathway in Colon Cancer
- (2010) Maria S. Pino et al. GASTROENTEROLOGY
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
- (2010) Alberto Bardelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
- (2010) Xing-xiang Pu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cancer Biomarkers: Can We Turn Recent Failures into Success?
- (2010) E. P. Diamandis JNCI-Journal of the National Cancer Institute
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Down-regulation of miR-126 expression in colorectal cancer and its clinical significance
- (2010) Xiang-Min Li et al. MEDICAL ONCOLOGY
- Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds
- (2010) Min-Hsiung Pan et al. MOLECULAR NUTRITION & FOOD RESEARCH
- The emerging mechanisms of isoform-specific PI3K signalling
- (2010) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- DNA Sequence Profiles of the Colorectal Cancer Critical Gene Set KRAS-BRAF-PIK3CA-PTEN-TP53 Related to Age at Disease Onset
- (2010) Marianne Berg et al. PLoS One
- PI3-kinase/Wnt association mediates COX-2/PGE2 pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenac
- (2010) Jasmeet Kaur et al. TUMOR BIOLOGY
- Regulatory Effect of the AMPK-COX-2 Signaling Pathway in Curcumin-Induced Apoptosis in HT-29 Colon Cancer Cells
- (2009) Yun-Kyoung Lee et al. Annals of the New York Academy of Sciences
- The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas
- (2009) K Shoji et al. BRITISH JOURNAL OF CANCER
- Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation
- (2009) Bijay S. Jaiswal et al. CANCER CELL
- AKT1 E17 K pleckstrin homology domain mutation in urothelial carcinoma
- (2009) Dorit E. Zilberman et al. CANCER GENETICS AND CYTOGENETICS
- PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
- (2009) A. Sartore-Bianchi et al. CANCER RESEARCH
- Targeted Inhibition of Mammalian Target of Rapamycin Signaling Inhibits Tumorigenesis of Colorectal Cancer
- (2009) P. Gulhati et al. CLINICAL CANCER RESEARCH
- Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer
- (2009) Anna Isinger Ekstrand et al. Familial Cancer
- Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma
- (2009) Ki-Seok Jang et al. HISTOPATHOLOGY
- PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer
- (2009) Fotios Loupakis et al. JOURNAL OF CLINICAL ONCOLOGY
- PIK3CAMutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer
- (2009) Shuji Ogino et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting the mTOR Signaling Network for Cancer Therapy
- (2009) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- FrequentPIK3CAgene amplification and its clinical significance in colorectal cancer
- (2009) Zeenath Jehan et al. JOURNAL OF PATHOLOGY
- Curcumin Synergizes With Resveratrol to Inhibit Colon Cancer
- (2009) Adhip P. N. Majumdar et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K
- (2009) J M Askham et al. ONCOGENE
- Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival
- (2008) Hirozumi Sawai et al. BMC GASTROENTEROLOGY
- Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
- (2008) B. Levin et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab
- (2008) M. Jhawer et al. CANCER RESEARCH
- Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
- (2008) William M. Grady et al. GASTROENTEROLOGY
- The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers
- (2008) Chunguang Guo et al. GENES CHROMOSOMES & CANCER
- Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers
- (2008) Ludovic Barault et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of Proline-rich Akt Substrate of 40 kDa (PRAS40) Function by Mammalian Target of Rapamycin Complex 1 (mTORC1)-mediated Phosphorylation
- (2008) Lifu Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis
- (2008) P. G. Rychahou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis
- (2008) T. Szado et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti cancer effects of curcumin: cycle of life and death
- (2008) Gaurisankar Sa et al. Cell Division
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started